HUANG Jie, WANG Bin-chao, YANG Xue-ning, WU Yi-long. Reflections From the IMforte Study: The Evolution of First-Line Treatment Paradigms for Extensive-Stage Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2025, 25(4): 191-194. DOI: 10.12019/j.issn.1671-5144.202508019
|
Citation:
|
HUANG Jie, WANG Bin-chao, YANG Xue-ning, WU Yi-long. Reflections From the IMforte Study: The Evolution of First-Line Treatment Paradigms for Extensive-Stage Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2025, 25(4): 191-194. DOI: 10.12019/j.issn.1671-5144.202508019
|
HUANG Jie, WANG Bin-chao, YANG Xue-ning, WU Yi-long. Reflections From the IMforte Study: The Evolution of First-Line Treatment Paradigms for Extensive-Stage Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2025, 25(4): 191-194. DOI: 10.12019/j.issn.1671-5144.202508019
|
Citation:
|
HUANG Jie, WANG Bin-chao, YANG Xue-ning, WU Yi-long. Reflections From the IMforte Study: The Evolution of First-Line Treatment Paradigms for Extensive-Stage Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2025, 25(4): 191-194. DOI: 10.12019/j.issn.1671-5144.202508019
|
DownLoad: